Bone and Soft Tissue Tumor Department

The Department of Bone and Soft Tissue Oncology of Tianjin Medical University Cancer Hospital was founded in 1979 to train a large number of specialist talents for domestic cancer hospitals. It is a specialty bone and soft tissue tumor specialty integrating surgery, functional rehabilitation, psychological treatment and nursing. The director of the department was Zhang Yunxiang, followed by Song Jingang and Fang Zhiwei.

Since 2008, Wang Guowen, a postdoctoral fellow in bone tumors, has been the director of the department. Under the leadership of director Wang Guowen, it has become routine for the department to perform total vertebral resection and reconstruction, total sacrum resection and reconstruction, and hemipelvic resection and reconstruction. The department's advantage has always been in the resection and reconstruction of giant soft tissue tumors.

The department currently has 2 doctoral supervisors (Wang Guowen), 2 chief physicians, 5 deputy chief physicians, 5 attending physicians, and 2 lecturers, including 7 with doctorate degrees, 3 with master's degrees, 1 rehabilitation therapist, and 1 psychotherapist. In 2017, the department had 16,448 outpatient visits, treated 1,972 patients annually, and performed 1,233 surgeries.

Director Wang Guowen has been in charge of the work for 10 years, and the department has made great progress. The department is a member of the Tianjin Anti-Cancer Association's Bone and Soft Tissue Tumor Specialty, and the Tianjin Medical Doctors Association's Bone Tumor Specialty Chairman Unit. Director Wang Wangowen has academic part-time positions in many academic organizations such as the Bone Oncology Group of the Orthopedic Branch of the Chinese Medical Association, the Sarcoma Professional Committee of the Chinese Anti-Cancer Association, and the Chinese Medical Doctors Association, and is a member of the World Limb Salvage Society (ISLOS).

Director Wang Guowen is one of the earliest researchers in China to study the mechanism of dedifferentiated chondrosarcoma. He has conducted research on radiofrequency ablation-assisted open surgery for the treatment of spinal tumors, and gave a speech in this regard at the 19th World Limb Salvage Congress held in Kanazawa, Japan, in 2017.

In recent years, he has undertaken 2 international cooperation projects, 5 National Natural Science Foundation projects, 3 provincial and ministerial level projects, 2 Tianjin Municipal Science and Technology Commission projects, 2 Tianjin Municipal Education Commission projects, 2 Tianjin Medical University projects and 4 hospital-level projects. He has published more than 80 papers in domestic and foreign journals, which are included in SCI He has 33 articles with the highest impact factor of 8.791 and a cumulative impact factor of more than 80 points. He has won two third prizes of the Municipal Science and Technology Progress Award, one first prize and one second prize of the Tianjin Medical University Science and Technology Award. He has compiled "Modern Surgical Treatment of Soft Tissue Sarcoma" and "English-Chinese-Chinese Orthopedic Glossary".

Participated in the compilation of "New Practical Orthopedics", "Physical Examination of Spine and Extremities", "Clinical Diagnosis of Bone and Joint Diseases", "Tumor Surgery", "Concise Oncology", "Practical Orthopedic Surgery Atlas", "Tumor TNM Staging Atlas", "Chinese Expert Consensus on the Surgical Treatment of Multiple Myeloma Bone Disease", "Guidelines for the Diagnosis and Treatment of Malignant Melanoma", "Chinese Expert Consensus on the Diagnosis and Treatment of Soft Tissue Sarcomas", etc., and participated in the translation of many oncology monographs.

In recent years, the department has made great progress in the treatment of axial bone tumors. The team with Director Wang Guowen as the core, including the anesthesiology department, interventional department, intensive care department, operating room and other departments, has actively cooperated and has independently completed the three most difficult surgeries recognized in the world: posterior total vertebral body surgery. Resection (enblock), pelvic tumor resection mainly for pelvic area II tumors, artificial hemipelvic reconstruction surgery, and total sacrum resection and reconstruction surgery. In addition, we are at the forefront of molecular pathological diagnosis and targeted drug application in the country, and are at the forefront of soft tissue malignant tumor resection.